The PARPi treatment can enhance GSDMC mediated pyroptosis and GSDMC can sensitize tumor cells to PARPi via an immune-dependent manner, which forms a positive feedback loop to achieve a better treatment response [184]. The gene discussed is GSDMC; the disease is neoplasm.